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Background: Previous studies investigating the association between GDF5 rs143383 polymorphism and knee
osteoarthritis (OA) have suggested stronger associations in Asians than Caucasians, but limitations on the amount
of available data have meant that a definitive assessment has not been possible. Given the availability of more recent
data, the aim of this meta-analysis was to determine the overall association between GDF5 rs143383 polymorphism
and knee OA and whether the association varies by ethnicity.
Methods: Searches of Medline, Embase, and ISI Web of Science were conducted up to July 2013. Summary odds ratios
(ORs) and 95% confidence intervals (CIs) were calculated to estimate the strength of association between the GDF5
polymorphism and knee OA risk.
Results: A total of 20 studies with 23,995 individuals were included. There were weak but significant associations
present between the GDF5 polymorphism and knee OA at the allele level (C vs. T: OR =0.85, 95% CI = 0.80-0.90) and
genotype level (CC vs. TT: OR = 0.73; CT vs. TT: OR = 0.84; CC/CT vs. TT: OR = 0.81; CC vs. CT/TT: OR = 0.81) in the overall
population. In the subgroup analysis by ethnicity, we observed a strong significant association (OR = 0.60 to 0.80, all
P <0.05) in Asian population and weaker associations (OR =0.78 to 0.87, all P <0.05) in Caucasian population; however
marked heterogeneity was detected in all models except for CC vs. TT (I2 = 12.9%) and CC vs. CT + TT (I2 = 0.0%) in
Asians.
Conclusions: These results strongly suggest that the C allele and CC genotype of the GDF5 gene are protective for
knee OA susceptibility across different populations.
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Osteoarthritis (OA) is the most prevalent form of arthritis
in the worldwide and is regarded as a disorder of the
whole joint [1,2]. One of the most frequently affected
joints is the knee, with a prevalence of 30% in those over
65 years old [3]. There is a strong genetic component of
OA with heritability estimates showing that genetic com-
ponents account for 39-65% of the risk for the develop-
ment of knee OA [2,4,5]. However, the identification of
specific genes has been problematic with some genes asso-
ciated with pain [6,7] and others with joint structures [8].
Overall, there is a lack of consistency of associations.* Correspondence: Feng.Pan@utas.edu.au
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unless otherwise stated.One of the most comprehensively studied candidate
genes is growth differentiation factor 5 (GDF5). GDF5,
also known as cartilage-derived morphogenetic protein 1,
is a member of the transforming growth factor-β super-
family and closely correlated with bone morphogenetic
proteins. GDF5 has been shown to be involved in muscu-
loskeletal processes including the development, mainten-
ance and repair of bone, cartilage and other tissues of
synovial joint as well as tendon [9,10]. In light of the im-
portant functions of GDF5, any changes affecting a reduc-
tion in the expression of this protein could increase the
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several disorders of skeletal development [11]. Single-
nucleotide polymorphisms (SNPs) have been identified in
the 5′-untranslated region (5′-UTR) of GDF5 which is in-
volved in the regulation of GDF5 transcriptional activity
[12]. As for one of the most common polymorphisms
(rs143383), T to C substitution in the promoter region of
GDF5 has an effect on the expression of GDF5 produc-
tion, with lower GDF5 expression of the OA-associated T
allele [13]. Several studies have suggested that GDF5
rs143383 polymorphism may be related to an elevated risk
of OA in certain ethnic groups [12,14-16]. However, these
positive associations have not been consistently replicated.
For instance, two studies from Korea and Greece failed to
detect any association with knee OA [17,18]. Two earlier
meta-analyses suggested that an increase in the risk of
knee OA was associated with GDF5 rs143383 polymorph-
ism in Asians and Caucasians [11,19]. Since then, multiple
studies on the relationship of knee OA with GDF5 have
been published. Therefore, the aim of this study was to de-
termine the overall association between GDF5 rs143383
polymorphism and knee OA risk and whether the associ-
ation varies by ethnicity.
Methods
Literature search strategy
We searched Medline, Embase and ISI Web of science da-
tabases for all English articles on the association between
GDF5 gene promoter polymorphism and OA (last report
up to 13 July 2013). Combinations of keywords used in
the search were: (“Growth differentiation factor 5” or
“GDF5” or “rs143383” or “+104 T/C”), (“polymorphism”
or “polymorphisms”) and (“osteoarthritis” or “OA”).
References of retrieved studies and review articles were
also screened for other additional eligible publications
and unpublished studies. Conference abstracts were not
considered.
Inclusion and exclusion criteria
All studies included in this meta-analysis had to meet
the following criteria: (1) the type of study was a case–
control or cohort study; (2) a study investigated the as-
sociation of GDF5 (rs143383; +104 T/C) polymorphism
with knee OA; (3) available alleles or genotypes frequen-
cies of GDF5 were provided to evaluate the odds ratios
(ORs) with 95% confidence intervals (CIs). The exclusion
criteria were as follows: (1) the study was not conducted
on knee OA; (2) the study was conducted on animals or
cells; (3) the data could not be extracted after contacting
with the authors.
Data extraction
All data were extracted independently from eligible stud-
ies by two reviewers (Pan and Tian) according to thecriteria listed above. The following information were
collected: the first author’s name, publication date, country
of origin, study design, ethnicity, total sample size of cases
and controls, genotype and allele frequencies of cases and
controls, sources of controls, age, sex and genotyping
method, which also were reviewed by a third investigator
(Jones). We also extracted data on how knee OA was de-
fined i.e. clinical criteria, radiographic criteria, or total
knee replacement (TKR). For clinical criteria, the Ameri-
can College of Rheumatology (ACR) criteria was used if
information on ACR was available [20]. For radiographic
criteria, Kellgren/Lawrence (K/L) score (0–4 scale) was
used to identify and grade knee OA. A cut-off of K/L score
2 was used to be a classification of knee OA [21]. Any
controversies about interpretation of data were discussed
within our research team to reach a consensus. In cases
where the same patient population was included in differ-
ent studies, only the larger sample size was included in
this meta-analysis. If one study contains the results from
different populations, each group was treated independ-
ently. Authors were contacted where unpublished data or
clarification were needed.
Statistical methods
Allele frequencies at GDF5 rs143383 polymorphism from
the respective study were determined by the allele count-
ing method. The strength of the association between
GDF5 rs143383 polymorphism and knee OA susceptibility
was estimated by calculating the pooled ORs with their
95% CIs. The Z-test was used to determine the signifi-
cance of the pooled ORs and 95% CIs. The pooled ORs
were performed for additive (C vs. T), co-dominant (CC
vs. TT; CT vs. TT), dominant (CC + CT vs. TT), and re-
cessive (CC vs. CT + TT) models. The between-study het-
erogeneity was assessed using the Chi square based Q-
statistic [22]. If a P value less than 0.10 for the Q-test was
observed, it indicates the presence of heterogeneity among
studies [23]. The I2 statistic (I2 = 100% × (Q-df)/Q) was
also used to quantify heterogeneity. I2 ranges from 0 to
100% which is interpreted as the degree of inconsistency
across studies [24]. An I2 greater than 50% was considered
as heterogeneity among studies. The random-effect model
was used to determine the pooled ORs. Sensitivity analysis
was performed by excluding the Hardy-Weinberg equilib-
rium (HWE)-violating studies [25]. Potential publication
bias was assessed by the funnel plot, in which the standard
error of log (OR) of each study was plotted against its log
(OR). A symmetric plot indicates a low risk of publication
bias. If visual inspection suggested there was funnel plot
asymmetry, the method of Egger’s linear regression test
was used to further assess [26]. All statistical analyses were
carried out using STATA version 7.0 (Stata Corporation,
College Station, TX). Two-sided P <0.05 was considered
to be statistically significant.
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Characteristics of included studies
A total of 12 articles were identified [11,12,14-19,27-30].
Among these, one article [12] reported on a Japanese
population and a Chinese population, these were con-
sidered as two separate studies. Two other studies per-
formed by Southam et al. [14] and Valdes et al. [27]
also included two independent studies, the former con-
tained UK and Spanish studies, and the latter investi-
gated two different populations in the UK. In addition,
the three previous meta-analyses included unpublished
data from independent studies [11,19,30] where only T
allele and C allele counts can be extracted from the
Twins UK and Finnish study [19], and the Rotterdam
study III [30]. Thus, 20 studies with 8,709 cases and
15,286 controls were included in the current meta-
analysis. The study flow chart is shown in Figure 1.
Detailed characteristics of these studies are listed in
Tables 1 and 2. Of eligible studies, 6 studies (n = 6,219)
and 14 studies (n = 17,776) were conducted respectively
in Asian and Caucasian populations. Male and female
subgroups were available from 5 studies in Asian and 4
studies in Caucasian population.Figure 1 Flow diagram of the study selection process. aP: population gQuantitative assessment
The summary of meta-analyses for GDF5 rs143383 poly-
morphism with OA is shown in Table 3.
Overall population
20 separate studies had available data for analysis of
GDF5 rs143383 polymorphism and knee OA risk with a
total sample size of 8,709 cases and 15,286 controls. In
the allele model and genotype models, significant associ-
ations were found when all studies were pooled in the
overall population (Table 3). The summary OR for allele
model was 0.85 (95% CI = 0.80-0.90). The forest plot of
the distribution of the ORs for allele model is shown in
Figure 2. Similarly, the summary ORs for genotype
models ranged from 0.73 to 0.84. There was substantial
and statistically significant heterogeneity for CT vs. TT
(I2 = 62.2%) and dominant model (I2 = 61.7%).
Subgroup analyses by ethnicity
Protective effects in Asian populations were consistently
greater in magnitude and the associations were all sta-
tistically significant in the Asian subgroup except for
CT versus TT which approached but did not reachroup; E: exposure; C: control group; O: outcome; S: study design.
Table 1 Characteristics of individual studies included in meta-analysis
First author Year Country Study design Ethnicity Sample size Source of
controls
Genotyping method Age (mean) Knee OA definition
Case Control Case Control Radiographic* Clinical† TKR
Southama 2007 UK Case–control Caucasian 349 822 HB PCR-RFLP 65 69 +
Southamb 2007 Spain Case–control Caucasian 274 1196 HB TaqMan NA >55.0 +
Miyamotoa 2007 Japan Case–control Asian 718 861 HB TaqMan, Invader, DNA fragment analysis
or Direct sequence
71.9 49.4 +
Miyamotob 2007 China Case–control Asian 313 485 HB TaqMan, Invader, DNA fragment analysis
or Direct sequence
58.8 56.8 +
Tsezou 2007 Greece Case–control Caucasian 251 268 HB Direct sequence 67.9 65.2 +
Chapman 2008 Netherlands Cohort study Caucasian 142 724 PB Mass spectrometry 60.4 59.6 +
Valdesa 2009 UK Case–control Caucasian 735 654 HB Allele-specific PCR 68.5 66.9 +
Valdesb 2009 UK Cohort study Caucasian 264 512 PB Allele-specific PCR 66.3 63 +
Vaes 2009 Netherlands Cohort study Caucasian 667 2097 PB TaqMan >55.0 >55.0 +
Evangeloua 2009 Iceland Cohort study Caucasian 1071 1169 PB Centaurus platform 74.8 74.8 +
Evangeloub 2009 UK Twins study Caucasian 177 548 NA Illumina platform 54.3 54.3 +
Evangelouc 2009 Finland Family-based study Caucasian 109 209 NA Mass spectrometry 67 58 + +
Cao 2010 Korea Case–control Asian 276 298 PB PCR-RFLP 63 44 +
Tawonsawatruk 2011 Thailand Case–control Asian 103 103 HB PCR-RFLP 68.5 59.25 +
Valdea 2011 UK Cohort study Caucasian 867 758 PB Allele-specific PCR 66.5 66.5 +
Valdesb 2011 Estonian Cohort study Caucasian 65 427 PB Allele-specific PCR 47.1 47.1 +
Valdesc 2011 UK Cohort study Caucasian 1141 536 PB Allele-specific PCR 65.5 65.5 + +
Valdesd 2011 Netherlands Cohort study Caucasian 162 1582 PB TaqMan >45.0 >45.0 +
Shin 2012 Korea Cohort study Asian 725 1737 PB High resolution melting analysis 67.4 62.7 +
Mhishra 2013 India Case–control Asian 300 300 HB PCR-RFLP 54.0 55.2 + +
a,b,c and dDenote an independent study in the one article, respectively; NA Data not available; HB hospital-based; PB population-based; PCR-RFLP polymerase chain reaction restriction fragment length polymorphism;
TKR total knee replacement.
*Radiographic criteria (Kellgren/Lawrence grade ≥2).



















Table 2 Distributions of GDF5 rs143383 genotypes and alleles among cases and controls
First author Year Case Control Case Control PHWE
TT TC CC TT TC CC T C T C
Southama 2007 141 168 40 324 372 126 450 248 1020 624 0.262
Southamb 2007 102 136 36 439 563 194 340 208 1441 951 0.550
Miyamotoa 2007 444 243 31 473 330 58 1131 305 1276 446 0.966
Miyamotob 2007 197 97 19 244 193 48 491 135 681 289 0.283
Tsezou 2007 95 126 30 99 125 44 316 186 323 213 0.669
Chapman 2008 54 72 16 289 331 104 180 104 909 539 0.558
Valdesa 2009 337 313 85 238 329 79 987 483 805 487 0.032
Valdesb 2009 126 98 35 181 244 84 350 168 606 412 0.908
Vaes 2009 276 298 93 752 1014 331 850 484 2518 1617 0.724
Evangeloua 2009 535 379 157 552 442 175 1449 693 1546 792 0.000
Evangeloub 2009 NA NA NA NA NA NA 230 124 679 417 NA
Evangelouc 2009 NA NA NA NA NA NA 124 94 251 167 NA
Cao 2010 150 115 11 159 113 26 415 137 431 165 0.360
Tawonsawatruk 2011 38 41 11 33 47 23 117 63 113 93 0.424
Valdesa 2011 413 361 93 294 354 110 1187 547 942 574 0.837
Valdesb 2011 32 24 9 168 179 80 88 42 515 339 0.010
Valdesc 2011 467 511 163 219 237 80 1445 837 675 397 0.229
Valdesd 2011 NA NA NA NA NA NA 195 107 1930 1234 NA
Shin 2012 382 305 38 942 689 106 1069 381 2573 901 0.176
Mhishra 2013 124 130 46 84 160 56 378 222 328 272 0.188
a,b,c and dDenote an independent study in the one article, respectively; HWE Hardy-Weinberg equilibrium; NA Data not available.
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highly significant especially for CC vs. TT (OR = 0.60,
P <0.001) and the recessive model (OR = 0.68, P <0.001)
(Figure 3). In the Asian subgroup, the between-study het-
erogeneity remained substantial apart from two models
(CC vs. TT and the recessive model, I2 = 12.9% and I2 =
0.0%, respectively). In Caucasian populations, similar
results were found under all models with weaker asso-
ciations (OR = 0.78 to 0.87, all P <0.05), but a lower
heterogeneity was observed.
Subgroup analyses by sex
When 9 studies with a sample size of females (n = 7,203)
and males (n = 4,733) were stratified by sex, there were no
significant differences in effects between males and fe-
males (Table 3). In females, all models showed significant
associations. A stronger significant association was ob-
served for CC vs. TT (OR = 0.73, P <0.001) in comparison
with other models in males, similarly, there were signifi-
cant differences for CC vs. TT and recessive model in fe-
males with the strongest association being for CC vs. TT
(OR = 0.65, P = 0.001) (Figure 4). Furthermore, not all as-
sociations were significant in males (CT vs. TT: OR =
0.99, 95% CI = 0.81-1.20; CC/CT vs. TT: OR = 0.90, 95%
CI = 0.74-1.09). Intriguingly, stratification by sex reducedheterogeneity in both males and females in all models
compared to that seen in the overall population. In fe-
males, substantial and statistically significant heterogeneity
persisted only for CT vs. TT (I2 = 53.2%) and dominant
models (I2 = 50.7%). In males, I2 < 50% was observed in all
models.
Evaluation of other potential sources of heterogeneity
In addition to evaluation of sources of heterogeneity by
ethnicity and sex, we also further investigated other po-
tential sources of heterogeneity by control types and
knee OA definition (Table 4). Subgroup analysis by con-
trol types found that heterogeneity of hospital-based
group was partly attenuated with I2 = 0% for CC vs. TT
and recessive model; however, significant heterogeneity
still was seen in the population-based group. When strati-
fication by knee OA definition, a significant reduction in
the heterogeneity (I2 < 41.0%) was observed where TKR
was used to define the cases but not for those studies
using radiographic criteria.
Sensitivity analyses
Sensitivity analyses were performed by excluding the
HWE-violating studies to evaluate the stability of the re-
sults. Departure from HWE was observed in the controls
Table 3 Meta-analysis of GDF5 rs143383 polymorphism and knee OA
Population Comparison (Na) Test of association Test of heterogeneity
OR (95% CI) Pb Pc I2 (%)
Overall C vs. T (20) 0.85 (0.80-0.90) 0.000 0.019 44.1
CC vs. TT (17) 0.73 (0.66-0.81) 0.000 0.328 10.8
CT vs. TT (17) 0.84 (0.76-0.94) 0.002 0.000 62.2
CC/CT vs. TT (17) 0.81 (0.73-0.90) 0.000 0.000 61.7
CC vs. CT/TT (17) 0.81 (0.74-0.86) 0.000 0.623 0.0
Ethnicity
Asian C vs. T (6) 0.78 (0.67-0.92) 0.003 0.006 69.5
CC vs. TT (6) 0.60 (0.48-0.76) 0.000 0.333 12.9
CT vs. TT (6) 0.80 (0.63-1.02) 0.071 0.002 74.3
CC/CT vs. TT (6) 0.76 (0.60-0.96) 0.021 0.001 75.8
CC vs. CT/TT (6) 0.68 (0.56-0.84) 0.000 0.494 0.0
Caucasian C vs. T (14) 0.87 (0.82-0.92) 0.000 0.229 20.7
CC vs. TT (11) 0.78 (0.70-0.87) 0.000 0.611 0.0
CT vs. TT (11) 0.86 (0.76-0.97) 0.012 0.011 56.2
CC/CT vs. TT (11) 0.83 (0.75-0.93) 0.001 0.020 52.6
CC vs. CT/TT (11) 0.84 (0.76-0.93) 0.001 0.822 0.0
Sex
Females C vs. T (9) 0.85 (0.78-0.93) 0.000 0.236 23.3
CC vs. TT (9) 0.73 (0.62-0.87) 0.000 0.923 0.0
CT vs. TT (9) 0.81 (0.69-0.95) 0.011 0.029 53.2
CC/CT vs. TT (9) 0.80 (0.69-0.93) 0.003 0.039 50.7
CC vs. CT/TT (9) 0.83 (0.70-0.97) 0.021 0.990 0.0
Males C vs. T (9) 0.85 (0.74-0.97) 0.020 0.171 30.9
CC vs. TT (9) 0.65 (0.50-0.84) 0.001 0.464 0.0
CT vs. TT (9) 0.99 (0.81-1.20) 0.888 0.139 34.8
CC/CT vs. TT (9) 0.90 (0.74-1.09) 0.272 0.107 39.1
CC vs. CT/TT (9) 0.66 (0.51-0.84) 0.001 0.613 0.0
OR odds ratio, CI confidence interval, aNumber of comparison, bP values for within group differences were determined by Z test, cP P value of Q-test for
heterogeneity test.
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the corresponding ORs did not materially alter under all
models, suggesting that the results of this meta-analysis
are stable (data not shown).
Evaluation of publication bias
Begger’s funnel plot was firstly performed to assess the
publication bias. As shown in Figure 5, no obvious
asymmetry was found by the shape of the funnel except
for CC vs TT and recessive model. Egger’s test was then
performed for statistical test, revealing there might be
publication bias under CC versus TT and recessive
model.
Discussion
To our knowledge, this is the largest and most compre-
hensive meta-analysis to assess the association of GDF5rs143383 polymorphism with knee OA, including data
from 20 studies in 8,709 knee OA cases and 15,286 con-
trols. Overall analysis of pooled results demonstrated a
statistically significant association between the variant
genotype of GDF5 and knee OA risk in all comparisons.
When stratification by ethnicity, significant associations
were found in Asian as well as in Caucasian populations
with a greater effect sizes in Asian population, suggest-
ing that GDF5 rs143383 polymorphism is a determinant
for knee OA risk and shared between Asian and Cauca-
sian populations.
GDF5, an extracellular signalling molecule, plays a
critical role in the development, maintenance and repair
of synovial joint tissues, and it has been suggested that
deficiency of GDF5 is one of the most important risk
factors for the pathogenesis of OA [10]. The expression
of the GDF5 protein is modulated by the GDF5 gene,
Figure 2 Forest plot of the association of GDF5 rs143383 polymorphism with knee osteoarthritis risk under additive model (C versus T).
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several disorders of skeletal development, such as chon-
drodysplasias and brachydactyly, suggesting this gene
has a crucial role in joint homeostasis and repair [17].
Several animal models have further confirmed the evi-
dence supporting a critical role of GDF5 [31-34]. In miceFigure 3 Forest plots for statistically significant meta-analysis in Asianwith GDF5 mutation, a number of abnormalities of joint
were found including the decrease in appendicular skel-
eton and the limb long bones, soft tissue deformities and
tendon anomaly. Taken together, these results imply that
GDF5 polymorphism may have an important function in
the aetiology and pathogenesis of OA.populations. (A) CC versus TT; (B) CC versus CT/TT.
Figure 4 Subgroup analysis by sex for knee osteoarthritis risk associated with GDF5 rs143383 polymorphism under CC versus TT model.
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tective for knee OA susceptibility (OR = 0.85, 95% CI =
0.80-0.90, P <0.001), and T allele of GDF5 was associated
with a higher risk for knee OA development. These find-
ings seem to be biologically plausible. The T allele of the
rs143383 SNP has been shown to be associated with a re-
duction in GDF5 transcriptional activity, thereby increas-
ing the risk of developing knee OA, compared with the
GDF5 C allele [12,14]. In the subgroup analysis by ethni-
city, effects sizes were consistently greater in Asian popu-
lations as compared to Caucasian populations, indicatingTable 4 Identifying the source of heterogeneity by control ty
Subgroup C vs. T CC vs. TT
Ph I
2 (%) Ph I
2 (%)
Source of controls
HB 0.196 29.1 0.681 0.0
PB 0.051 46.6 0.233 23.7
Knee OA definition
Radiographic 0.043 48.3 0.654 0.0
TKR 0.206 30.5 0.132 41.0
HB hospital-based, PB population-based, TKR total knee replacement, Ph, P value ofthat the same gene polymorphism may have different roles
in knee OA susceptibility among different racial back-
grounds, and the difference in linkage disequilibrium pat-
terns may exist [19].
Several meta-analyses have been performed to identify
the association between the GDF5 variant and knee OA
risk. In a previous meta-analysis by Chapman et al. [11]
including 2,207 cases and 4,356 controls, a significant
association of GDF5 rs143383 polymorphism with knee
OA was observed in Asians as well as Caucasians. In an-
other meta-analysis, Evangelou et al. [19] included 5,085pe and knee OA definition
CT vs. TT CC/CT vs. TT CC vs. CT/TT
Ph I
2 (%) Ph I
2 (%) Ph I
2 (%)
0.013 60.8 0.032 54.4 0.703 0.0
0.006 62.9 0.005 64.0 0.511 0.0
0.003 68.1 0.002 68.9 0.874 0.0
0.187 33.3 0.184 33.6 0.153 38.0
Q-test for heterogeneity test.
Figure 5 Funnel plot and Egger’s publication bias plot for meta-analysis on association between GDF5 rs143383 polymorphism and
knee osteoarthritis risk (C versus T). (A) Begg’s funnel plot for meta-analysis; (B) Egger’s linear regression test for publication bias.
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polymorphism was associated with the risk of knee OA.
In the subgroup analysis, the same association was ob-
served across different populations. Although two recent
meta-analyses also suggested that GDF5 rs143383 poly-
morphism was associated with knee OA susceptibility,
their results should be interpreted with caution [35,36].
In the study performed by Liu et al. [35], all OA cases
were pooled into their study and subgroup analyses by
joint site, ethnicity, and sex were not performed. In the
study by Hao and Jin [36] comprising 6 studies with 2,744
cases and 4,518 controls, there was incomplete identifica-
tion of publications, which may distort the results [37].
Valdes et al. [30] also performed the meta-analysis with
the largest sample size (7,579 cases and 11,947 controls),
reporting that the T allele of the GDF5 polymorphism is
associated with a 17% elevated risk for knee OA. Consist-
ent with this, the present meta-analysis with a larger sam-
ple size showed a similar effect size of T allele for knee
OA in the overall population. However, we found a
slightly lower risk estimate for the T allele (OR = 1.15)
in Caucasian population as compared to the Valdes’
paper (OR = 1.16). This discrepancy may be due to in-
consistency of reporting data from the Rotterdam I study.
In the current paper, data from this study was extracted
from one of the original papers reporting Rotterdam I
study [28] rather than from a previous meta-analysis [19],
thereby leading to a slight data variation. Additionally, the
GDF5 polymorphism was found to be consistently associ-
ated with knee OA risk in Asian population. This further
provides strong evidence of GDF5 rs143383 polymorph-
ism to knee OA risk across different populations.
Heterogeneity is a potential problem in the understand-
ing the results of meta-analyses. In this study, significant
heterogeneity between different studies was observed in
the overall population. To clarify the source of heterogen-
eity, ethnicity and sex were used to stratify the studies,finding part of this heterogeneity can be effectively attenu-
ated or removed when stratification by sex. This indicates
that it is important for meta-analyses of genetic associ-
ation studies to perform subgroup analyses by sex. After
subgroup analysis by source of controls, the heterogeneity
was also decreased; therefore, it can be assumed that the
heterogeneity partly results from difference of source of
controls. That may be because potential confounding fac-
tors in many epidemiologic studies may result from the
difference in control types [38]. In addition, different stud-
ies used different criteria to define the cases, which might
be one of sources of heterogeneity. Some centres defined
their cases using the K/L classification and/or ACR cri-
teria, whereas other centres used a TKR to define their
cases. These differences between studies in the control
group as well as key characteristics of the participants
might lead to heterogeneity in the magnitude of the gen-
etic effects [19]. Therefore, a broad consensus should be
reached about OA phenotype definitions and how to enrol
an ideal control group. Furthermore, other factors also
should be explored to identify the source of heterogeneity
if more data was available.
Of note, several potential limitations of this study should
be acknowledged. Firstly, knee OA is a multifactorial dis-
ease with complex associations between genetic factors
and environmental factors, and is a polygenic disease that
could not be conferred significantly by no loci individually
[39,40]. Hence, some environmental factors or other poly-
morphic loci should be taken into account together to ar-
rive at a true effect of GDF5 gene. Secondly, in view of
our results from unadjusted estimates, a more accurate as-
sessment should be performed according to age, body
mass index, smoking status, and other lifestyle factors if
more detailed data were available. Thirdly, publication bias
was found in two models, which may give rise to biased
results, in particular potentially an overestimate of the ef-
fect. However, unpublished studies would need to have a
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stantially change our results.
Conclusions
This meta-analysis suggests that GDF5 rs143383 poly-
morphism is highly associated with the susceptibility to
knee OA with protective associations for the C allele and
CC genotype across different populations.
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